Philippines Readies Regulations, Rules For Cheaper Drugs
This article was originally published in PharmAsia News
New regulations are set to go into effect in mid-November in the Philippines aimed at reducing the cost of certain drugs. The regulations and rules implement the Universally Accessible Cheaper and Quality Medicines Act of 2008 and provide for importing generic drugs and setting maximum prices at the retail level where stores also will be required to carry both generics and branded drugs. The law, enacted in July, is to take effect 15 days after rules and regulations were published, set for Nov. 4. A Department of Health undersecretary said the parallel-import provisions of the law might be amended later to meet some complaints about the draft. (Click here for more
You may also be interested in...
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
As one of the leading players in the US, albeit with a declining core business, Sandoz is naturally watching developments from the Federal Circuit’s precedential ruling on induced infringement for carved out indications. Management discussed the topic as Sandoz reported third-quarter financials.